{"id":"standard-treatment-with-saline-infusion","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperchloremic acidosis"},{"rate":null,"effect":"Fluid overload / pulmonary edema"},{"rate":null,"effect":"Hypokalemia"},{"rate":null,"effect":"Phlebitis at infusion site"}]},"_chembl":{"chemblId":"CHEMBL2108783","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Saline infusion is a standard supportive therapy that restores intravascular volume and corrects electrolyte imbalances. It is used across multiple clinical contexts including dehydration, perioperative fluid management, and as a vehicle for drug delivery. The mechanism is purely physiological rather than pharmacological.","oneSentence":"Saline infusion replaces or maintains fluid and electrolyte balance by delivering isotonic sodium chloride solution intravenously.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:38:05.528Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dehydration and hypovolemia"},{"name":"Perioperative fluid maintenance"},{"name":"Electrolyte imbalance correction"},{"name":"Vehicle for intravenous drug administration"}]},"trialDetails":[{"nctId":"NCT01453088","phase":"PHASE2","title":"Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older","status":"TERMINATED","sponsor":"Hackensack Meridian Health","startDate":"2010-06-24","conditions":"Multiple Myeloma","enrollment":63},{"nctId":"NCT07362446","phase":"PHASE2","title":"Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction","status":"NOT_YET_RECRUITING","sponsor":"Nyrada Pty Ltd","startDate":"2026-04-16","conditions":"Myocardial Infarction, Reperfusion Injury, AMI","enrollment":300},{"nctId":"NCT04763343","phase":"PHASE3","title":"Ketamine Treatment of Youth Suicide Attempters","status":"RECRUITING","sponsor":"Tatiana Falcone, MD","startDate":"2022-06-27","conditions":"Suicide, Attempted","enrollment":60},{"nctId":"NCT04899908","phase":"PHASE2","title":"Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-09-15","conditions":"Brain Cancer, Brain Metastases, Melanoma","enrollment":134},{"nctId":"NCT06408597","phase":"NA","title":"Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nazmy Edward Seif","startDate":"2024-05-12","conditions":"Prostate Cancer, Bladder Cancer, Surgery","enrollment":90},{"nctId":"NCT03258593","phase":"PHASE1","title":"Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2018-06-07","conditions":"Urinary Bladder Neoplasms","enrollment":15},{"nctId":"NCT04512235","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-11-03","conditions":"AL Amyloidosis","enrollment":281},{"nctId":"NCT04504825","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-08-25","conditions":"AL Amyloidosis","enrollment":125},{"nctId":"NCT04488081","phase":"PHASE2","title":"I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2020-07-31","conditions":"COVID-19","enrollment":1500},{"nctId":"NCT07387354","phase":"PHASE1, PHASE2","title":"Pacritinib With Aza for Upfront Myelodysplastic Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2026-05","conditions":"Myelodysplastic Syndromes, MDS, Myelodysplastic Syndrome, Unclassifiable","enrollment":25},{"nctId":"NCT07472270","phase":"PHASE1","title":"Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment","status":"NOT_YET_RECRUITING","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2026-03-15","conditions":"Liver Cirrhosis","enrollment":12},{"nctId":"NCT04862221","phase":"PHASE2","title":"TReatment for ImmUne Mediated PathopHysiology","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-02-09","conditions":"Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy","enrollment":163},{"nctId":"NCT05304715","phase":"PHASE2","title":"Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2022-04-13","conditions":"Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome","enrollment":44},{"nctId":"NCT03644667","phase":"PHASE2","title":"Tocilizumab in Cardiac Transplantation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-12-20","conditions":"Heart Transplant","enrollment":385},{"nctId":"NCT04263181","phase":"","title":"AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2020-01-29","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndromes","enrollment":80},{"nctId":"NCT07440069","phase":"PHASE4","title":"Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor","status":"RECRUITING","sponsor":"Universidad Nacional Autonoma de Honduras","startDate":"2026-02-15","conditions":"Labor Pain","enrollment":300},{"nctId":"NCT07438847","phase":"PHASE1","title":"177Lu-CTR-FAPI for the Treatment of Thyroid Cancer","status":"RECRUITING","sponsor":"SHAOYAN LIU","startDate":"2026-01-01","conditions":"Thyroid Cancer","enrollment":12},{"nctId":"NCT07441226","phase":"PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients","status":"RECRUITING","sponsor":"RSUP Persahabatan","startDate":"2025-08-08","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":20},{"nctId":"NCT04052334","phase":"PHASE1","title":"Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-09-27","conditions":"Sarcoma","enrollment":9},{"nctId":"NCT06994442","phase":"PHASE3","title":"Optimizing Pain Treatment in Children On Mechanical Ventilation","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2025-12-29","conditions":"Mechanical Ventilation, Pediatric Acute Respiratory Failure, Analgesics, Opioid","enrollment":644},{"nctId":"NCT07424378","phase":"PHASE4","title":"Epoprostenol Plus Conventional Therapy in COld and Frostbite Injury (ECCO)","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-02","conditions":"Frostbite","enrollment":66},{"nctId":"NCT07409259","phase":"EARLY_PHASE1","title":"PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2026-01-01","conditions":"Acute-on-Chronic Liver Failure (ACLF)","enrollment":20},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT04368559","phase":"PHASE3","title":"Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mundipharma Research Limited","startDate":"2020-05-11","conditions":"Candidemia, Mycoses, Fungal Infection","enrollment":602},{"nctId":"NCT06381934","phase":"NA","title":"Validation of New Diagnostic Indices to Simplify Hyponatremia Therapy Assessment in Patients on Thiazide Diuretics","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-05-06","conditions":"Thiazide Associated Hyponatremia","enrollment":136},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT07393386","phase":"PHASE4","title":"Intrapleural Bupivacaine Analgesia for Postoperative Pain Management After Minimally Invasive Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2026-02-01","conditions":"Pain Management","enrollment":249},{"nctId":"NCT01237054","phase":"PHASE2","title":"Imaging in MGUS, SMM and MM","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2010-10-17","conditions":"Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance","enrollment":31},{"nctId":"NCT07201519","phase":"PHASE2","title":"Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy","status":"RECRUITING","sponsor":"Michael J Cavnar, MD","startDate":"2026-01-23","conditions":"Colorectal Cancer Metastatic, Intrahepatic Cholangiocarcinoma","enrollment":80},{"nctId":"NCT03040999","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-04-05","conditions":"Head and Neck Neoplasms","enrollment":804},{"nctId":"NCT07189091","phase":"PHASE4","title":"CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS","status":"RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2025-10-07","conditions":"Critical Care, Intensive Care, Fluid Accumulation, Fluid and Electrolyte Imbalance","enrollment":640},{"nctId":"NCT03101891","phase":"PHASE1","title":"Renal Anhydramnios Fetal Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2018-12-21","conditions":"Anhydramnios, Potter Syndrome, Lung Hypoplasia","enrollment":70},{"nctId":"NCT05056220","phase":"PHASE3","title":"Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites","status":"RECRUITING","sponsor":"Aleksander Krag","startDate":"2024-02-26","conditions":"Decompensated Cirrhosis and Ascites","enrollment":240},{"nctId":"NCT07380347","phase":"PHASE3","title":"Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2026-02","conditions":"Neonatal Sepsis","enrollment":50},{"nctId":"NCT07366710","phase":"NA","title":"Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2024-11-05","conditions":"Glucose Metabolism, NAFLD (Nonalcoholic Fatty Liver Disease)","enrollment":36},{"nctId":"NCT05776004","phase":"PHASE2","title":"Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eagle Pharmaceuticals, Inc.","startDate":"2023-07-22","conditions":"Pneumonia, Bacterial","enrollment":276},{"nctId":"NCT07152600","phase":"PHASE3","title":"Adaptive RCT of Corticosteroids for Severe Adenovirus Pneumonia in Adults","status":"NOT_YET_RECRUITING","sponsor":"Qingyuan Zhan","startDate":"2026-02-01","conditions":"Adenovirus Infections, Human","enrollment":262},{"nctId":"NCT04910269","phase":"PHASE3","title":"Outpatient Treatment With Anti-Coronavirus Immunoglobulin","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2021-08-06","conditions":"COVID, SARS-CoV2 Infection, Covid19","enrollment":820},{"nctId":"NCT07352865","phase":"PHASE3","title":"Adaptive RCT of Corticosteroids for Severe Chlamydia Psittaci Pneumonia in Adults","status":"NOT_YET_RECRUITING","sponsor":"Qingyuan Zhan","startDate":"2026-01-15","conditions":"Psittacosis","enrollment":100},{"nctId":"NCT07353749","phase":"PHASE4","title":"Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms","status":"NOT_YET_RECRUITING","sponsor":"Duan Chuanzhi","startDate":"2026-01-30","conditions":"Unruptured Intracranial Aneurysms, Cerebrovascular Event, Hemorrhagic Stroke","enrollment":864},{"nctId":"NCT07351500","phase":"PHASE3","title":"Adaptive RCT of Corticosteroids for Severe Influenza Pneumonia in Adults","status":"NOT_YET_RECRUITING","sponsor":"Qingyuan Zhan","startDate":"2026-01-15","conditions":"Influenza","enrollment":496},{"nctId":"NCT07327476","phase":"NA","title":"Effect of Oral Ice Chips to Prevent Chemotherapy-Induced Oral Mucositis in Patient With Solid Tumor Treated With 5 Fluorouracil and Methotrexate","status":"NOT_YET_RECRUITING","sponsor":"University of Health Sciences Lahore","startDate":"2026-03-01","conditions":"Chemotherapy Induced Oral Mucositis","enrollment":102},{"nctId":"NCT06129175","phase":"PHASE2, PHASE3","title":"UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX)","status":"RECRUITING","sponsor":"Cytopeutics Sdn. Bhd.","startDate":"2023-12-19","conditions":"Acute Ischemic Stroke","enrollment":80},{"nctId":"NCT07167797","phase":"NA","title":"Evaluation of the Role of Vitamin D in Reducing the Severity and Duration of Rotavirus Infection in Iraqi Children","status":"COMPLETED","sponsor":"University of Baghdad","startDate":"2025-01-01","conditions":"Rotaviral Gastroenteritis","enrollment":60},{"nctId":"NCT05956418","phase":"PHASE4","title":"A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients","status":"RECRUITING","sponsor":"Pharmazz, Inc.","startDate":"2021-08-13","conditions":"Hypovolemic Shock","enrollment":400},{"nctId":"NCT07274254","phase":"PHASE3","title":"Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease","status":"NOT_YET_RECRUITING","sponsor":"Nantes University Hospital","startDate":"2026-03-01","conditions":"Vaso-Occlusive Pain Episode in Sickle Cell Disease","enrollment":104},{"nctId":"NCT06065371","phase":"PHASE1","title":"Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy","status":"RECRUITING","sponsor":"Henry Ford Health System","startDate":"2024-11-20","conditions":"Gastrointestinal Cancer","enrollment":20},{"nctId":"NCT07150819","phase":"NA","title":"A Multidisciplinary Perioperative Pain Management","status":"WITHDRAWN","sponsor":"China-Japan Friendship Hospital","startDate":"2022-07-01","conditions":"Anorectal Surgery, Pain Management","enrollment":""},{"nctId":"NCT07287371","phase":"PHASE4","title":"Sucrosomial Vs Intravenous Iron for Preoperative Anemia","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2025-12-31","conditions":"Anemia, Iron Deficiency Anemia","enrollment":75},{"nctId":"NCT05645107","phase":"PHASE3","title":"A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma","status":"RECRUITING","sponsor":"Grifols Therapeutics LLC","startDate":"2022-12-26","conditions":"Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia","enrollment":386},{"nctId":"NCT03999229","phase":"PHASE1","title":"S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion","status":"RECRUITING","sponsor":"James Reynolds","startDate":"2019-07-25","conditions":"Transfusion Related Complication","enrollment":35},{"nctId":"NCT07073846","phase":"PHASE4","title":"Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.","status":"RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-10-06","conditions":"Morbid Obesity Requiring Bariatric Surgery, Postoperative Pain, Postoperative Pain Management","enrollment":104},{"nctId":"NCT07250867","phase":"PHASE2","title":"Safety and Efficacy of Lidocaine Versus Ketamine Infusion for Resistant Orofacial Pain","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-01","conditions":"Orofacial Pain","enrollment":105},{"nctId":"NCT06313801","phase":"PHASE2","title":"Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions","status":"RECRUITING","sponsor":"Nizhny Novgorod Regional Clinical Oncology Center","startDate":"2023-01-19","conditions":"Gastric Cancer","enrollment":106},{"nctId":"NCT07240701","phase":"PHASE4","title":"Normal Saline Versus Ringer's Lactate for Initial Fluid Resuscitation in Sepsis","status":"NOT_YET_RECRUITING","sponsor":"Egemen Yildiz","startDate":"2025-11","conditions":"Sepsis","enrollment":88},{"nctId":"NCT06052787","phase":"PHASE3","title":"Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-09-01","conditions":"Traumatic Brain Injury","enrollment":150},{"nctId":"NCT07153445","phase":"PHASE2","title":"Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)","status":"RECRUITING","sponsor":"Fundación GECP","startDate":"2025-07-08","conditions":"Non Small Cell Lung Cancer, Stage IIIA Lung Cancer, Stage IIIB Lung Cancer","enrollment":97},{"nctId":"NCT07232082","phase":"NA","title":"Assessing Local Hypothermia and Endovascular Recanalization for Acute Stroke With a Large Core Infarction","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Wannan Medical College","startDate":"2025-12-01","conditions":"Stroke, Large Ischemic Core","enrollment":322},{"nctId":"NCT07229456","phase":"PHASE3","title":"Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ain Shams University","startDate":"2024-10-01","conditions":"Corrosive Injury","enrollment":80},{"nctId":"NCT07229495","phase":"PHASE4","title":"Tegileridine for Postoperative Pain After Adolescent Scoliosis Surgery","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-01-01","conditions":"Scoliosis; Adolescence, Pain After Surgery, Analgesia, Patient-controlled","enrollment":171},{"nctId":"NCT03036488","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-03-07","conditions":"Triple Negative Breast Neoplasms","enrollment":1174},{"nctId":"NCT04678401","phase":"PHASE1","title":"IS-free Treg HaploHCT","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2021-01-12","conditions":"Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute","enrollment":30},{"nctId":"NCT07208344","phase":"EARLY_PHASE1","title":"Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease","status":"RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2025-07-31","conditions":"Alzheimer Disease (AD)","enrollment":30},{"nctId":"NCT05253339","phase":"NA","title":"The Expected Advantage of Administering Prophylactic Antibiotics Using Target- Concentration Controlled Infusion","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2022-04-04","conditions":"Anti-bacterial Agents, Pharmacokinetics, General Surgery","enrollment":2494},{"nctId":"NCT07179003","phase":"PHASE2","title":"A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-04","conditions":"Breast Abscess","enrollment":50},{"nctId":"NCT06819956","phase":"PHASE3","title":"Ketorolac at Lower Doses for Analgesic Pain Control in ICU: A Pilot Feasibility Study","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-06-23","conditions":"Pain Management","enrollment":30},{"nctId":"NCT07179874","phase":"NA","title":"Remote Ischemic Preconditioning to Prevent Contrast-Induced Kidney Injury in Diabetic Patients (PRINCES)","status":"COMPLETED","sponsor":"Universidad de Murcia","startDate":"2015-02-25","conditions":"Contrast-induced Acute Kidney Injury","enrollment":71},{"nctId":"NCT07178379","phase":"NA","title":"Hysteroscopy Anesthesia for Relief of Pain","status":"NOT_YET_RECRUITING","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2025-09-06","conditions":"Pain Management, Outpatient Hysteroscopy, Local Anesthesia","enrollment":70},{"nctId":"NCT04258956","phase":"PHASE2","title":"A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy","status":"COMPLETED","sponsor":"Maria Sklodowska-Curie National Research Institute of Oncology","startDate":"2019-04-30","conditions":"Gastrointestinal Stromal Tumors","enrollment":58},{"nctId":"NCT03970447","phase":"PHASE2, PHASE3","title":"A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma","status":"RECRUITING","sponsor":"Global Coalition for Adaptive Research","startDate":"2019-07-30","conditions":"Glioblastoma","enrollment":1280},{"nctId":"NCT07156656","phase":"PHASE4","title":"Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-09-01","conditions":"Type A Aortic Dissection, Organ Failure, Multiple","enrollment":236},{"nctId":"NCT06567691","phase":"NA","title":"Endoscopic Gastroenterostomy Versus Surgical Gastrojejunostomy","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2025-08-01","conditions":"Malignant Gastric Outlet Obstruction","enrollment":34},{"nctId":"NCT05967871","phase":"PHASE1","title":"Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth","status":"RECRUITING","sponsor":"McMaster Children's Hospital","startDate":"2024-03-11","conditions":"Small Intestinal Bacterial Overgrowth","enrollment":20},{"nctId":"NCT07131306","phase":"PHASE2","title":"National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2027-01","conditions":"Acute-On-Chronic Liver Failure","enrollment":100},{"nctId":"NCT07075315","phase":"PHASE3","title":"National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2028-01","conditions":"Acute-On-Chronic Liver Failure","enrollment":100},{"nctId":"NCT07091994","phase":"PHASE4","title":"A Prospective, Multicentre, Randomized Controlled Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy","status":"NOT_YET_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2025-08-01","conditions":"Ischemic Stroke, Acute, Active Malignancies","enrollment":144},{"nctId":"NCT03673748","phase":"PHASE2","title":"Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"Red de Terapia Celular","startDate":"2022-12-27","conditions":"Lupus Nephritis, Lupus Erythematosus","enrollment":20},{"nctId":"NCT05944458","phase":"PHASE4","title":"Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients","status":"COMPLETED","sponsor":"Helwan University","startDate":"2023-08-01","conditions":"Linezolid, Antioxidant, Thrombocytopenia","enrollment":250},{"nctId":"NCT03725059","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-12-27","conditions":"Breast Cancer","enrollment":1240},{"nctId":"NCT07043686","phase":"NA","title":"Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2025-06-13","conditions":"Ischemic Stroke, Acute, Rehabilitation Outcome, Cerebrolysin","enrollment":30},{"nctId":"NCT05713630","phase":"PHASE3","title":"The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma","status":"NOT_YET_RECRUITING","sponsor":"Unity Health Toronto","startDate":"2025-09-30","conditions":"Subdural Hematoma","enrollment":130},{"nctId":"NCT05717062","phase":"PHASE2","title":"Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO)","status":"COMPLETED","sponsor":"Ophirex, Inc.","startDate":"2023-05-30","conditions":"Snakebite, Envenoming, Snake","enrollment":140},{"nctId":"NCT07035561","phase":"PHASE2","title":"Rituximab Therapy in Patients With Treatment Refractory Hypersenstivity Pneumonitis","status":"COMPLETED","sponsor":"Shereen Medhat Mohammed Elsayed Nassar","startDate":"2023-06-01","conditions":"Hypersenstivity Pneumonitis, ILD","enrollment":30},{"nctId":"NCT05577585","phase":"NA","title":"Ketamine in OCD: Efficacy and Effects on Stress and Cognition","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2022-10-01","conditions":"Obsessive-Compulsive Disorder, Psychiatric Disorder","enrollment":60},{"nctId":"NCT06955416","phase":"PHASE2, PHASE3","title":"REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis","status":"RECRUITING","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2025-05-01","conditions":"Diabetic Ketoacidosis","enrollment":312},{"nctId":"NCT04832009","phase":"EARLY_PHASE1","title":"Reversing Glucose and Lipid-mediated Vascular Dysfunction","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-05-09","conditions":"Blood Pressure, Hypertension","enrollment":46},{"nctId":"NCT00518869","phase":"PHASE2, PHASE3","title":"Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue","status":"TERMINATED","sponsor":"PhytoHealth Corporation","startDate":"2007-09","conditions":"Quality of Life, Fatigue, Complementary","enrollment":13},{"nctId":"NCT06713382","phase":"PHASE2","title":"Evaluating the Efficacy and Safety of Saline Irrigation as an Add-On Therapy for Retained Pleural Infections [LYTICS +]","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2025-04-10","conditions":"Pleural Effusion Associated With Pulmonary Infection, Pleural Effusion Disorder, Pleural Effusions","enrollment":96},{"nctId":"NCT06863558","phase":"PHASE3","title":"Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-05-08","conditions":"Intracerebral Hemorrhage","enrollment":58},{"nctId":"NCT04325594","phase":"PHASE1, PHASE2","title":"The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Non-ischemic Heart Failure","status":"COMPLETED","sponsor":"The Research-Clinical Center for Cardiac Surgery and Transplantology LLP","startDate":"2020-03-01","conditions":"Chronic Heart Failure, Non-ischemic Cardiomyopathy, Non-ischemic Dilated Cardiomyopathy","enrollment":30},{"nctId":"NCT06863571","phase":"PHASE3","title":"Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Ischemic Stroke","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-04-12","conditions":"Ischemic Stroke","enrollment":68},{"nctId":"NCT04625530","phase":"PHASE3","title":"Perioperative Management in Gynaecological Carcinoma Surgery","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-08-01","conditions":"Gynaecological Carcinoma","enrollment":""},{"nctId":"NCT06572085","phase":"PHASE4","title":"Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients","status":"RECRUITING","sponsor":"Tang Ziren","startDate":"2022-01-01","conditions":"Butylphthalide, Cardiac Arrest, Neuroprotective Drugs","enrollment":350},{"nctId":"NCT05684276","phase":"PHASE2","title":"DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors","status":"RECRUITING","sponsor":"Fundación GECP","startDate":"2023-05-12","conditions":"NSCLC, Pancoast Tumor","enrollment":22},{"nctId":"NCT06431633","phase":"PHASE3","title":"Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.","status":"RECRUITING","sponsor":"Fundación GECP","startDate":"2025-02-04","conditions":"Lung Diseases, Carcinoma, Non-Small-Cell Lung, Resectable Lung Non-Small Cell Carcinoma","enrollment":129},{"nctId":"NCT04564157","phase":"PHASE3","title":"New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación GECP","startDate":"2021-01-13","conditions":"Non-Small Cell Lung Cancer, Adjuvant Chemotherapy","enrollment":210},{"nctId":"NCT04776447","phase":"PHASE2","title":"Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación GECP","startDate":"2021-06-16","conditions":"Lung Diseases, Carcinoma, Non-Small-Cell Lung, Stage IIIA Non-small Cell Lung Cancer","enrollment":38},{"nctId":"NCT05012254","phase":"PHASE2","title":"Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación GECP","startDate":"2021-11-18","conditions":"Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer","enrollment":71},{"nctId":"NCT06890650","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Crohn Disease","enrollment":168},{"nctId":"NCT06890637","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Crohn Disease on Advanced Therapies","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Crohns Disease","enrollment":168}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":268,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Standard treatment with saline infusion","genericName":"Standard treatment with saline infusion","companyName":"University of Roma La Sapienza","companyId":"university-of-roma-la-sapienza","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Saline infusion replaces or maintains fluid and electrolyte balance by delivering isotonic sodium chloride solution intravenously. Used for Dehydration and hypovolemia, Perioperative fluid maintenance, Electrolyte imbalance correction.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}